By
Drug Target Review2025-04-11T08:30:52
Researchers at UTHealth Houston have initiated a new stem cell therapy trial aimed at reducing neuroinflammation to prevent Alzheimer's disease before symptoms emerge, an approach that could revolutionise treatment strategies, offering new hope for at-risk individuals.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2023-03-28T11:38:32
Sponsored by Bio-Techne
2026-03-11T14:00:00
Sponsored by Merck
2026-03-25T15:00:00 2026-03-25T16:00:00
Sponsored by Yokogawa
2023-01-04T16:08:55
Sponsored by Sartorius Incucyte® Live-Cell Analysis System
2023-03-08T16:29:20
Sponsored by Bio-Techne
2024-01-24T12:52:38
Sponsored by BellBrook Labs
Site powered by Webvision Cloud